Top Markets
#1 Verus Coin Verus Coin +19.70%
#2 Fake World Assets Fake World Assets +5.11%
#3 GoPlus Security GoPlus Security +4.67%
#4 TronBank TronBank +3.97%
#5 Everything Everything +3.70%
#6 TENDIES TENDIES +3.27%
#7 Bedrock Bedrock +2.68%
#8 Tutorial Tutorial +2.32%
#9 Janction Janction +2.16%
#10 Holoworld Holoworld +2.14%
Coin of the day
Verus Coin Verus Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Ultimovacs ASA Ultimovacs ASA

Ultimovacs ASA

ULTI
Rank in Stocks #34179
Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established... Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established in 2011. The firm specializes in developing immunotherapies to combat various cancers. Its main product in development is UV1, a peptide vaccine engineered to stimulate a T-cell immune response against telomerase, an antigen found widely across different cancer types.
Share Price
$0.17687105
Last synced: 2025-04-01
Market Cap
$6.08M
Change (1 day)
-89.96%
Change (1 year)
0.00%
Country
NO
Trade Ultimovacs ASA (ULTI)

Category

Healthcare
Earnings for Ultimovacs ASA (ULTI)
Earnings in 2026 TTM: 0
According to Ultimovacs ASA latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Ultimovacs ASA from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE